Clinical Trial Update: A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome. [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating the efficacy and safety of Uracyst versus placebo in patients with Interstitial Cystitis/Painful Bladder Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• Uracyst (sodium hyaluronate)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Interstitial Cystitis | Phase 2 | Status: COMPLETED